Ace Vision Group

    1 min read

    Insights from Industry Innovators

    Carey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.

    Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include:

    đŸ”¹Alex Lopez, Chief Commercial Officer – Ace Vision Group
    đŸ”¹Houman Hamadi, MD, PhD, Co-Founder & Chief Medical Officer – Optigo Biotherapeutics
    đŸ”¹Leanne Lavriola, DO, MBA, President & CEO – InnSight Technology
    đŸ”¹Nir Katchinskiy, PhD, CEO & Co-Founder – PulseMedica

    Resources:
    Ace Vision Group: https://acevisiongroup.com/
    Optigo Biotherapeutics: https://www.optigobio.com/
    InnSight Technology: https://www.innsightech.com/
    PulseMedica:  https://www.pulsemedica.com/

    Explore More Articles

    Ace Vision Group to Present Nine New Sets of Scientific Data Focused on Laser Scleral Microporation at the ESCRS Annual Meeting

    Ace Vision Group (AVG) announced it will present nine sets of research on the effectiveness of Laser Scleral Microporation (LSM) at the annual congress of the European Society of Cataract and Refractive Surgeons (ESCRS).  LSM is an ultra-minimally invasive procedure with a novel therapeutic approach to treating the aging eye. 

    read more

    Laser scleral microporation improves near vision in emmetropic presbyopes

    WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Robert E. Ang, MD, discusses results from a study of laser scleral microporation.

    read more

    Dr. Robert Ang in CRST 

    What other future treatments have promise?  Laser scleral microporation is under investigation as a laser treatment for patients with emmetropic presbyopia. Four quadrants of the sclera are treated with an Er:YAG laser to uncrosslink the sclera and rejuvenate the accommodative mechanism (see video demonstration below). Treatment does not appear to affect the visual axis or …

    read more

    Let’s Stay Connected

    Let’s Stay Connected

    Enter your email to receive news and updates
    *The VisioLite® Er:YAG Laser System is under development and has not been approved or cleared for commercial sale in the United States, European Union, United Kingdom, or other jurisdictions.